Long-term responders to trastuzumab monotherapy in first-line HER-2+advanced breast cancer: characteristics and survival data

Schmid, S; Klingbiel, D; Aebi, S; Goldhirsch, A; Mamot, C; Munzone, E; Nole, F; Oehlschlegel, C; Pagani, O; Pestalozzi, B; Rochlitz, C; Thurlimann, B; von Moos, R; Weder, P; Zaman, K; Ruhstaller, T

Schmid, S (reprint author), Kantonsspital, Breast Ctr St Gallen, Rorschacherstr 95, CH-9007 St Gallen, Switzerland.

BMC CANCER, 2019; 19 (1):

Abstract

BackgroundThe impact of HER2-targeted therapy alone followed by the addition of chemotherapy at disease progression (PD) versus upfront combination wa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索